Combined allergy treatment and anti-drying compositions and related methods

Abstract

Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition. The composition may further comprise an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition. The composition may be delivered into at least one of the human's nose, eyes, mouth, and throat.

1 . A method for treating an allergy condition and simultaneously reducing the drying effect of an allergy treatment composition in a human, the method comprising the steps of:
 identifying a human having an allergy condition;   providing a composition, wherein the composition comprises:
 an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition; and 
 an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition; and 
   delivering the composition comprising the allergy treatment composition and the anti-drying composition into at least one of the human's nose, eyes, mouth, and throat.   
     
     
         2 . The method of  claim 1 , wherein the anti-drying composition comprises at least one of xylitol, xylose, and erythiritol. 
     
     
         3 . The method of  claim 2 , wherein the anti-drying composition comprises at least one of xylitol and xylose. 
     
     
         4 . The method of  claim 1 , wherein the allergy treatment composition comprises a hydrochloride antihistamine. 
     
     
         5 . The method of  claim 4 , wherein the allergy treatment composition comprises at least one of phenylephrine hydrochloride, oxymetazoline hydrochloride, and azelastine hydrochloride. 
     
     
         6 . The method of  claim 1 , wherein the allergy treatment composition comprises at least one of cromolyn sodium, phenylephrine hydrochloride, oxymetazoline hydrochloride, azelastine hydrochloride, and mometasone furoate. 
     
     
         7 . The method of  claim 1 , wherein the composition comprises an aqueous solution. 
     
     
         8 . The method of  claim 7 , wherein the aqueous solution comprises a nasal solution, and wherein the step of delivering the composition comprising the allergy treatment composition and the anti-drying composition comprises delivering the nasal solution into the human's nose. 
     
     
         9 . The method of  claim 1 , wherein the composition comprises a nasal solution, and wherein the nasal solution comprises a gel. 
     
     
         10 . The method of  claim 1 , wherein the composition further comprises a thickening agent comprising at least one of methylcellulose, xanthan gum, carboxyl methylcellulose, polyvinyl alcohol, hydroxpropyl cellulose, a carbomer, a starch, a chitosan, and an acrylate. 
     
     
         11 . A method for treating an allergy condition and simultaneously reducing the drying effect of an allergy treatment composition in a human, the method comprising the steps of:
 identifying a human having an allergy condition;   providing a nasal solution, wherein the nasal solution comprises:
 an allergy treatment composition comprising an antihistamine comprising at least one of cromolyn sodium, mometasone furoate, and a hydrochloride antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition; and 
 an anti-drying composition comprising at least one of xylitol, erythiritol, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition; and 
   delivering the nasal solution comprising the allergy treatment composition and the anti-drying composition into the human's nose.   
     
     
         12 . A solution for treating an allergy condition and simultaneously reducing the drying effect of an allergy treatment composition in the nasal solution, the solution comprising:
 an allergy treatment composition in a therapeutically effective amount for treating an allergy condition in a human having the allergy condition; and   an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition.   
     
     
         13 . The solution of  claim 12 , wherein the allergy treatment composition comprises at least one of an antihistamine, a nasal steroid, cromolyn sodium, phenylephrine hydrochloride, oxymetazoline hydrochloride, azelastine HCL, mometasone furoate, and a decongestant. 
     
     
         14 . The solution of  claim 12 , wherein the allergy treatment composition comprises an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition. 
     
     
         15 . The solution of  claim 14 , wherein the antihistamine comprises a natural antihistamine. 
     
     
         16 . The solution of  claim 15 , wherein the natural antihistamine comprises at least one of echinacea, chamomile, and basil. 
     
     
         17 . The solution of  claim 12 , wherein the solution comprises a nasal solution, and wherein the nasal solution is configured to be administered by way of at least one of a nasal spray and a dropper. 
     
     
         18 . The solution of  claim 17 , wherein the nasal solution comprises a gel. 
     
     
         19 . The solution of  claim 12 , wherein the anti-drying composition comprises at least one of xylitol, xylose, and erythiritol. 
     
     
         20 . The solution of  claim 19 , wherein the anti-drying composition comprises at least one of xylitol and xylose.